11:10 AM EDT, 10/22/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving slightly lower late Tuesday morning, declining 0.13% to 1,397.40 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and Grifols ( GRFS ) , which rose 2.7% and 1.8%, respectively. They were followed by software firm SAP (SAP) and internet browser company Opera (OPRA), which were up 1.7% and 1.3%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and internet advertising company Criteo ( CRTO ) , which fell 4.2% and 2.7%, respectively. They were followed by financial services company ING (ING) and pharmaceutical company Ascendis Pharma ( ASND ) , which were down 2% and 1.3%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and tobacco company British American Tobacco (BTI), which increased 7.1% and 1.4%, respectively. They were followed by hospitality company InterContinental Hotels Group ( IHG ) and financial services company Lloyds Banking Group ( LYG ) , which rose 0.9% and 0.8%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which lost 5.5% and 3.2%, respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and software firm Endava (DAVA), which dropped 3% and 2.4%, respectively.